Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.
D000409:Alanine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D003838:Deoxyadenine Nucleotides / Q000378:metabolism; D003854:Deoxyribonucleotides / Q000378:metabolism; D016049:Didanosine; D054306:Dideoxynucleotides; D006678:HIV / Q000187:drug effects / Q000472:pathogenicity*; D007288:Inosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009711:Nucleotides / Q000378:metabolism; D013601:T-Lymphocytes / Q000382:microbiology
D003838:Deoxyadenine Nucleotides; D003854:Deoxyribonucleotides; D054306:Dideoxynucleotides; D009711:Nucleotides; C037773:2',3'-dideoxyadenosine triphosphate; C000082:alanosine; D007288:Inosine; D016049:Didanosine; D000409:Alanine